Quick Answer
FATE THERAPEUTICS INC reported Stockholders Equity of $207.18 million for the year ending 2025.
- FATE THERAPEUTICS INC showed a decrease of -35.0% in Stockholders Equity from 2024 to 2025.
- This data is from FATE THERAPEUTICS INC's annual report (Form 10-K), filed with the SEC on February 26, 2026.
- XBRL data for this metric is available from 2009 to 2025 (17 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q4 2013: $50.85 million | Q1 2014: $45.18 million | Q2 2014: $39.64 million | Q3 2014: $33.58 million | Q1 2015: $21.25 million | Q2 2015: $51.07 million | Q3 2015: $45.00 million | Q1 2016: $30.73 million | Q2 2016: $23.13 million | Q3 2016: $25.37 million | Q1 2017: $63.86 million | Q2 2017: $55.21 million | Q3 2017: $45.75 million | Q1 2018: $65.00 million | Q2 2018: $51.83 million | Q3 2018: $173.93 million | Q1 2019: $145.84 million | Q2 2019: $127.53 million | Q3 2019: $268.04 million | Q1 2020: $219.22 million | Q2 2020: $474.11 million | Q3 2020: $424.37 million | Q1 2021: $790.10 million | Q2 2021: $752.07 million | Q3 2021: $730.33 million | Q1 2022: $633.39 million | Q2 2022: $580.48 million | Q3 2022: $518.00 million | Q1 2023: $477.47 million | Q2 2023: $437.76 million | Q3 2023: $402.78 million | Q1 2024: $426.12 million | Q2 2024: $396.98 million | Q3 2024: $362.33 million | Q1 2025: $288.41 million | Q2 2025: $261.36 million | Q3 2025: $234.07 million.
- Over the full 17 years of available data (2009 to 2025), FATE THERAPEUTICS INC's Stockholders Equity has grown by 1,065.6%.
- Historical annual values: Fiscal year 2025: $207.18 million | Fiscal year 2024: $318.73 million | Fiscal year 2023: $368.42 million | Fiscal year 2022: $483.94 million | Fiscal year 2021: $678.84 million | Fiscal year 2020: $384.45 million | Fiscal year 2019: $244.76 million | Fiscal year 2018: $160.47 million | Fiscal year 2017: $77.19 million | Fiscal year 2016: $73.15 million | Fiscal year 2015: $38.04 million | Fiscal year 2014: $28.34 million | Fiscal year 2013: $50.85 million | Fiscal year 2012: -$52.83 million | Fiscal year 2011: -$50.68 million | Fiscal year 2010: -$37.44 million | Fiscal year 2009: -$21.46 million.
- Data sourced from SEC EDGAR public filings as of August 5, 2026.
Last verified: